For about $200 per child, the seven-day mortality rate for newborns in Zambia dropped by 40 percent.

By mapping a patient’s genome, and their tumor’s, with whole-genome sequencing, physicians can use more targeted therapies.

Adding cystatin C to a diagnostic panel revealed one person in six who had chronic kidney disease that was undetected using the conventional test.

Tigatuzumab, developed at UAB with Daiichi-Sankyo, targets aggressive, hard-to-treat tumors that make up 25 percent of all breast cancers

UAB Comprehensive Cancer Center helps drop cancer disparities while brain tumor research holds promise for new therapies to fight gliomas

New technology and research may help detect and prevent skin cancer, but you can also take measures to avoid the disease.